Novartis India Acquires Minipress Trademarks from Pfizer in $132M Deal
Novartis India has entered into a deal with Pfizer for the acquisition of trademarks and related intellectual property rights associated with the 'Minipress' and 'Minipres' brands within India. The transaction is valued at approximately Rs 12.5 billion, equivalent to $132 million. This move aligns Novartis's strategy in expanding its portfolio through strategic acquisitions. The deal involves Pfizer transferring specific brand assets registered under the Minipress and Minipres names in India. Such transactions are common within the pharmaceutical industry as companies seek to consolidate or divest certain product lines based on market dynamics and business strategies.
Tickers: $NOVARTIND $NVS $PFE
Topics: intellectual property pharmaceuticals trademark acquisition